Biotech 2050 Podcast cover image

Biotech 2050 Podcast

Transforming Gene Therapy: Exclusive Insights from Zandy Forbes, President & CEO of MeiraGTx

Jul 24, 2024
Zandy Forbes, founder and CEO of MeiraGTx, discusses the evolution of gene therapy, manufacturing advancements, and the challenges and opportunities in the biotech sector. She highlights Meira's innovative approach to genetic medicines for non-inherited diseases, emphasizing strategies to navigate the complex landscape of biotech. The podcast explores controlling genes through oral pill dosing, optimizing capital efficiency, and diversifying disease areas with a technology-focused approach.
50:25

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • Zandy Forbes transitioned from academia to leading MeiraGTx, focusing on innovative gene therapies for non-inherited diseases.
  • Miro Therapeutics targets non-inherited diseases with genetic medicines utilizing oral small molecules for gene control.

Deep dives

Zandi Forbes' Career Journey and Academic Background

Zandi Forbes, the founder of Miro Therapeutics, discusses her academic journey, starting from studying molecular biology at Cambridge to conducting a PhD at Oxford on the genetic model organism, the fruit fly. Her work led her to understand gene control mechanisms and eventually transition into stem cell research and academic roles across various US universities.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner